The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
T cell redirecting and TLR7/8 agonist encapsulated liposomes targeting HER2+ tumors: Preclinical efficacy, pharmacokinetics and safety evaluations.
 
Anjie Zheng
Employment - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Honoraria - Hangzhou HighField Biopharmaceuticals
Consulting or Advisory Role - Hangzhou HighField Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - All-Trans Retinoic Acid liposome Formulation, And Preparation And Use Therexof
 
Shanshan Jin
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
Honoraria - HighField Biopharmaceuticals
 
Shuhang Wang
No Relationships to Disclose
 
Xuan Wu
Employment - HighField Biopharmaceuticals
 
Danting Xie
Employment - HighField Biopharmaceuticals; HighField Biopharmaceuticals
 
Jinfeng Long
Employment - HighField Biopharmaceuticals
 
Yongchao Dai
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
 
Fengwei Xu
Employment - HighField Biopharmaceuticals
Stock and Other Ownership Interests - HighField Biopharmaceuticals
 
Ning Li
No Relationships to Disclose
 
Yuhong Xu
Employment - Hangzhou HighField Biopharmaceuticals
Leadership - Hangzhou HighField Biopharmaceuticals
Stock and Other Ownership Interests - Hangzhou HighField Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - hold several patents, but currently no royalty generated